Publication Cover
Expert Review of Precision Medicine and Drug Development
Personalized medicine in drug development and clinical practice
Volume 5, 2020 - Issue 3
1,724
Views
2
CrossRef citations to date
0
Altmetric
Editorial

How can bioinformatics contribute to the routine application of personalized precision medicine?

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 115-117 | Received 20 Feb 2020, Accepted 16 Apr 2020, Published online: 07 May 2020

References

  • Shameer K, Badgeley MA, Miotto R, et al. Translational bioinformatics in the era of real-time biomedical, health care and wellness data streams. Brief Bioinform. 2017 Jan;18(1):105–124.
  • Rudman JR, Mei C, Bressler SE, et al. Precision medicine in hearing loss. J Genet Genomics. 2018 Feb 20;45(2):99–109.
  • De Guillebon E, Dardenne A, Saldmann A, et al. Beyond the concept of cold and hot tumors for the development of novel predictive biomarkers and the rational design of immunotherapy combination. Int J Cancer. 2020 Jan 30. DOI:10.1002/ijc.32889
  • Jamal-Hanjani M, Quezada SA, Larkin J, et al. Translational implications of tumor heterogeneity. Clin Cancer Res. 2015 Mar 15;21(6):1258–1266.
  • Turajlic S, Sottoriva A, Graham T, et al. Resolving genetic heterogeneity in cancer. Nat Rev Genet. 2019 Jul;20(7):404–416.
  • Gavan SP, Thompson AJ, Payne K. The economic case for precision medicine. Expert Rev Precis Med Drug Dev. 2018;3(1):1–9.
  • Wolf SM, Bonham VL, Bruce MA. How can law support development of genomics and precision medicine to advance health equity and reduce disparities? Ethn Dis. 2019 Dec 12;29(Suppl 3):623–628.
  • Prainsack B. The “We” in the “Me”: solidarity and health care in the era of personalized medicine. Sci Technol Hum Values. 2018;43(1):21–44.
  • Gómez-López G, Dopazo J, Cigudosa JC, et al. Precision medicine needs pioneering clinical bioinformaticians. Brief Bioinform. 2019 May 21;20(3):752–766.
  • Drysdale R, Cook CE, Petryszak R, et al. The ELIXIR core data resources: fundamental infrastructure for the life sciences. Bioinformatics. 2020 Jan 17. DOI:10.1093/bioinformatics/btz959
  • Piñeiro-Yáñez E, Reboiro-Jato M, Gómez-López G, et al. PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data. Genome Med. 2018 May 31;10(1). DOI:10.1186/s13073-018-0546-1
  • Baptista D, Ferreira PG, Rocha M. Deep learning for drug response prediction in cancer. Brief Bioinform. 2020 Jan 17. DOI:10.1093/bib/bbz171
  • Attwood TK, Blackford S, Brazas MD, et al. A global perspective on evolving bioinformatics and data science training needs. Brief Bioinform. 2019 Mar;20(2):398–404.
  • Via A, Attwood TK, Fernandes PL, et al. A new pan-European Train-the-Trainer programme for bioinformatics: pilot results on feasibility, utility and sustainability of learning. Brief Bioinform. 2019 Mar;20(2):405–415.
  • Saunders G, Baudis M, Becker R, et al. Leveraging European infrastructures to access 1 million human genomes by 2022. Nat Rev Genet. 2019 Nov;20(11):693–701.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.